Helicobacter pylori highlights from the first Canadian Digestive Disease Week.
The first annual Canadian Digestive Disease Week (CDDW) took place in Banff, Alberta from March 4 to 10, 1996. The CDDW meeting was attended by over 600 Canadian physicians, fellows and researchers, and included a Gastroenterology Fellows' Program, as well as Practitioners' and Scientific Programs. It was apparent from the posters and presentations that Helicobacter pylori research ongoing in Canada is at the leading edge. World leaders in H pylori research spoke on topics ranging from the genetics of H pylori and the pathogenesis of its associated diseases, to the clinical challenge of successful eradication of infection. This overview summarizes the information about H pylori presented at the 1996 CDDW.
Matisko
A
A
Department of Medicine, University of Alberta, Edmonton.
Thomson
A B
AB
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000897:Anti-Ulcer Agents / Q000627:therapeutic use; D002170:Canada; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis* / Q000188:drug therapy / Q000235:genetics; D016480:Helicobacter pylori / Q000302:isolation & purification*; D006801:Humans; D013274:Stomach Neoplasms / Q000209:etiology* / Q000503:physiopathology
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents